04/17/2024
3:33 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:19 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:41 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
8:33 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
5:28 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
8:12 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/11/2024
8:13 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
8:53 PM | ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/05/2024
3:42 PM | ANI Pharmaceuticals (Filer)
| Form ARS | |
04/02/2024
5:59 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:17 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:09 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
6:30 AM | ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
| Form SC 13D/A | |
03/13/2024
3:44 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:48 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:07 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
5:58 PM | ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
5:39 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:43 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:25 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:59 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
8:42 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:21 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:11 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:16 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:58 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
4:31 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:24 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:20 PM | ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:18 PM | ANI Pharmaceuticals (Subject)
Pera Antonio R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:09 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:12 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:18 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:55 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:22 AM | ANI Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
5:58 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:47 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:50 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:53 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The “Perfect Storm” for Gold (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
02/16/2024
3:34 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:38 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:26 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:05 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
5:06 AM | ANI Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024
7:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
5:14 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
4:32 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:52 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
3:30 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
5:20 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:06 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
3:32 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
6:45 AM | ANI Pharmaceuticals (Subject)
Esjay LLC (Filed by)
| Form SC 13D/A | |
01/16/2024
8:09 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
4:27 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:30 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
4:44 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:31 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
4:35 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
4:18 PM | ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
| Form SC 13D/A | |
12/15/2023
3:57 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
4:49 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:30 PM | ANI Pharmaceuticals (Subject)
Esjay LLC (Filed by)
| Form SC 13D/A | |
11/20/2023
7:58 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4/A | |
11/20/2023
8:05 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
2:24 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
5:11 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
5:13 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
4:18 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
4:48 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
7:32 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
5:57 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
6:01 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/19/2023
3:30 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023
3:28 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:57 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2023
3:57 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2023
3:32 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
4:06 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/13/2023
4:21 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2023
7:00 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
6:04 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:40 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
4:14 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:44 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
3:38 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/15/2023
3:42 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
7:01 AM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
5:24 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Biden’s $374B Giveaway Into This Sector (Ad) Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving
See what this $374B giveaway could mean for your retirement right here Click here for the full story |
09/11/2023
5:23 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:32 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
4:06 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
3:29 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
3:32 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2023
7:06 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2023
3:17 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
7:44 PM | ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
